Correlation Between Eliem Therapeutics and Eterna Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Eterna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Eterna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Eterna Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Eterna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Eterna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Eterna Therapeutics.
Diversification Opportunities for Eliem Therapeutics and Eterna Therapeutics
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eliem and Eterna is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Eterna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eterna Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Eterna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eterna Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Eterna Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Eterna Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.64 times more return on investment than Eterna Therapeutics. However, Eliem Therapeutics is 1.56 times less risky than Eterna Therapeutics. It trades about -0.28 of its potential returns per unit of risk. Eterna Therapeutics is currently generating about -0.28 per unit of risk. If you would invest 509.00 in Eliem Therapeutics on August 30, 2024 and sell it today you would lose (205.00) from holding Eliem Therapeutics or give up 40.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 97.73% |
| Values | Daily Returns |
Eliem Therapeutics vs. Eterna Therapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| Eterna Therapeutics |
Eliem Therapeutics and Eterna Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Eterna Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and Eterna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Eterna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eterna Therapeutics will offset losses from the drop in Eterna Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Eterna Therapeutics vs. Ikena Oncology | Eterna Therapeutics vs. Eliem Therapeutics | Eterna Therapeutics vs. HCW Biologics | Eterna Therapeutics vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |